CureVac N.V. CVAC
$ 2.48
-0.6%
Quarterly report 2022-Q2
added 08-18-2022
Country |
Germany |
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Franz-Werner Haas L.L.M., LLD, Ph.D., LL.M. |
Employees in the company |
500 |
Shares |
186 M |
Market Cap[1] |
$ 461 M |
EBITDA (LTM) |
$ -131 M |
P/E (LTM) |
-10.51 |
P/S (LTM) |
- |
EPS (LTM) |
-0.7 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.